- Most Recent Funding
- $1 Million on April 11, 2014 / Undisclosed Round
SISCAPA Assay Technologies, Inc. develops SISCAPA assays for high-value protein biomarkers and other proteins to enable precise measurement of human protein in clinical and other samples. The company offers SISCAPA assay reagents, including RabMAb, which are rabbit monoclonal anti-peptide antibodies; and isotope standard labeled peptides, unlabelled peptides, and magnetic beads for protein biomarkers. Its products are also used in commercial applications. The company provides SISCAPA licenses the technology to use for commercial research purposes, or to commercialize SISCAPA reagents; and kits or assay services. SISCAPA Assay Technologies, Inc. was incorporated in 2011 and is based in Washin...
Current Team (3)Update
759 Willard ST Nw
Washington, CA 20009